Pharmaceutical

Concordia outlined their growth strategy in Europe.

Concordia (NASDAQ:CXRX; TSX:CXR) outlined their strategy for their growth in Europe.
As quoted in the press release:

“At its essence, the DELIVER strategy will focus Concordia’s efforts on becoming a leading European specialty `off-patent’ medicines player,” said Concordia Chief Executive Officer Allan Oberman. “The development of this strategy was a multi-month initiative that was done internally, reflecting contributions from more than 50 Concordia employees including our senior management team, and our board of directors. It is the culmination of a holistic team effort that we are very excited about.”
Senior management and Concordia’s board of directors believe the name DELIVER is appropriate for this strategy because it is precisely what the Company intends to do, and it is an acronym that, letter by letter, defines the critical elements of the strategy.

Click here to read the full press release.

Source: www.newswire.ca

MARKETS

Markets
TSX20028.81-151.00
TSXV677.24-3.25
DOW33607.67-153.38
S&P 5004263.05-17.10
NASD13047.69+0.50
ASX7032.50-38.50

COMMODITIES

Commodities
Gold1780.79-18.34
Silver20.23-0.55
Copper3.57-0.10
Palladium2155.60-57.40
Platinum934.73-26.27
Oil87.53-4.56
Heating Oil3.42-0.10
Natural Gas8.50-0.27

DOWNLOAD FREE REPORTS

×